FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Scott Grundy

Research Profile

Chemicals & Drugs

Concepts & Ideas

Risk Factors

Disorders

Co-author Network

Publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Scott Grundy (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Scott M Grundy
Plasma noncholesterol sterols as indicators of cholesterol absorption.
Journal of lipid research 2013;54(4):873-5.
2013: Gloria Lena Vega; Scott M Grundy
Metabolic risk susceptibility in men is partially related to adiponectin/leptin ratio.
Journal of obesity 2013;2013():409679.
2012: Scott M Grundy
Treatment targets in the management of dyslipidemias: which targets in whom?
Current cardiology reports 2012;14(6):692-700.
2012: Magdalene Szuszkiewicz-Garcia; Nicola Abate; Scott M Grundy; Rong Li; Manisha Chandalia
Fat distribution and insulin resistance in young adult nonobese Asian Indian women.
Metabolic syndrome and related disorders 2012;10(5):326-30.
2012: Ian J Neeland; Tiffany M Powell-Wiley; Aslan T Turer; Gloria L Vega; Ramin Farzaneh-Far; Scott M Grundy; Amit Khera; Darren K McGuire; Colby R Ayers; James A de Lemos
Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults.
JAMA : the journal of the American Medical Association 2012;308(11):1150-9.
2012: Aslan T Turer; Gloria L Vega; Colby R Ayers; Jeffrey D Browning; Sandeep R Das; Scott M Grundy; Amit Khera; Philipp E Scherer
Adiponectin as an independent predictor of the presence and degree of hepatic steatosis in the Dallas Heart Study.
The Journal of clinical endocrinology and metabolism 2012;97(6):E982-6.
2012: Scott M Grundy; Carolyn Barlow; Stephen W Farrell; Gloria L Vega; William L Haskell
Cardiorespiratory fitness and metabolic risk.
The American journal of cardiology 2012;109(7):988-93.
2012: Scott M Grundy
Pre-diabetes, metabolic syndrome, and cardiovascular risk.
Journal of the American College of Cardiology 2012;59(7):635-43.
2012: James A de Lemos; Scott M Grundy
Low levels of circulating troponin as an intermediate phenotype in the pathway to heart failure.
Journal of the American College of Cardiology 2012;59(5):490-2.
2011: Gloria Lena Vega; Fredrick L Dunn; Scott M Grundy
Effect of colesevelam hydrochloride on glycemia and insulin sensitivity in men with the metabolic syndrome.
The American journal of cardiology 2011;108(8):1129-35.
2011: Darren K McGuire; Scott M Grundy
Interview with Dr. Scott Grundy during AHA EPI/NPAM meeting in March 2011.
Journal of clinical lipidology 2011;5(5):371-2.
2011: Scott M Grundy; Joanne E Tomassini; Gloria Lena Vega; Andrew M Tershakovec
Comparisons of apolipoprotein B levels estimated by immunoassay, nuclear magnetic resonance, vertical auto profile, and non-high-density lipoprotein cholesterol in subjects with hypertriglyceridemia (SAFARI Trial).
The American journal of cardiology 2011;108(1):40-6.
2011: Magdalene Szuszkiewicz; Jason Bell; Miguel Vazquez; Beverley Adams-Huet; Scott M Grundy; Manisha Chandalia; Nicola Abate
ENPP1/PC-1 K121Q and other predictors of posttransplant diabetes.
Metabolic syndrome and related disorders 2011;9(1):25-9.
2011: Kamakki Banks; Divijani Puttagunta; Sabina Murphy; Monica Lo; Darren K McGuire; James A de Lemos; Alice Y Chang; Scott M Grundy; Amit Khera
Clinical characteristics, vascular function, and inflammation in women with angina in the absence of coronary atherosclerosis: the Dallas Heart Study.
JACC. Cardiovascular imaging 2011;4(1):65-73.
2010: Tiffany M Powell; James A de Lemos; Kamakki Banks; Colby R Ayers; Anand Rohatgi; Amit Khera; Darren K McGuire; Jarett D Berry; Michelle A Albert; Gloria L Vega; Scott M Grundy; Sandeep R Das
Body size misperception: a novel determinant in the obesity epidemic.
Archives of internal medicine 2010;170(18):1695-7.
2010: Gloria Lena Vega; Carolyn Barlow; Scott M Grundy
Prevalence of the metabolic syndrome as influenced by the measure of obesity employed.
The American journal of cardiology 2010;105(9):1306-12.
2010: Susan G Lakoski; Fang Xu; Gloria Lena Vega; Scott M Grundy; Manisha Chandalia; Chun Lam; Robert S Lowe; Michael E Stepanavage; Thomas A Musliner; Jonathan C Cohen; Helen H Hobbs
Indices of cholesterol metabolism and relative responsiveness to ezetimibe and simvastatin.
The Journal of clinical endocrinology and metabolism 2010;95(2):800-9.
2009: Amit Khera; Gloria Lena Vega; Sandeep R Das; Colby Ayers; Darren K McGuire; Scott M Grundy; James A de Lemos
Sex differences in the relationship between C-reactive protein and body fat.
The Journal of clinical endocrinology and metabolism 2009;94(9):3251-8.
2009: Scott M Grundy; Gloria Lena Vega; Joanne E Tomassini; Andrew M Tershakovec
Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
The American journal of cardiology 2009;104(4):548-53.
2009: Meena Shah; Manisha Chandalia; Beverley Adams-Huet; Linda J Brinkley; Khashayar Sakhaee; Scott M Grundy; Abhimanyu Garg
Effect of a high-fiber diet compared with a moderate-fiber diet on calcium and other mineral balances in subjects with type 2 diabetes.
Diabetes care 2009;32(6):990-5.
2009: Gloria Lena Vega; Fredrick L Dunn; Scott M Grundy
Impaired hepatic ketogenesis in moderately obese men with hypertriglyceridemia.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2009;57(4):590-4.
2008: Scott M Grundy; Beverley Adams-Huet; Gloria Lena Vega
Variable contributions of fat content and distribution to metabolic syndrome risk factors.
Metabolic syndrome and related disorders 2008;6(4):281-8.
2008: Colleen Johnson; David D Waters; David A DeMicco; Andrei Breazna; Vera Bittner; Heiner Greten; Scott M Grundy; John C LaRosa
Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] Study).
The American journal of cardiology 2008;102(10):1312-7.
2008: Gloria Lena Vega; Jacob J Clarenbach; Fredrick Dunn; Scott M Grundy
Oxandrolone enhances hepatic ketogenesis in adult men.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2008;56(7):920-4.
2008: John J P Kastelein; Wim A van der Steeg; Ingar Holme; Michael Gaffney; Nilo B Cater; Philip Barter; Prakash Deedwania; Anders G Olsson; S Matthijs Boekholdt; David A Demicco; Michael Szarek; John C LaRosa; Terje R Pedersen; Scott M Grundy
Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment.
Circulation 2008;117(23):3002-9.
2008: Karen Chen; Jason B Lindsey; Amit Khera; James A De Lemos; Colby R Ayers; Abhinav Goyal; Gloria L Vega; Sabina A Murphy; Scott M Grundy; Darren K McGuire
Independent associations between metabolic syndrome, diabetes mellitus and atherosclerosis: observations from the Dallas Heart Study.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2008;5(2):96-101.
2008: Gloria Lena Vega; Manisha Chandalia; Lidia S Szczepaniak; Scott M Grundy
Effects of N-3 fatty acids on hepatic triglyceride content in humans.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2008;56(5):780-5.
2008: Raphael See; Jason B Lindsey; Mahesh J Patel; Colby R Ayers; Amit Khera; Darren K McGuire; Scott M Grundy; James A de Lemos
Application of the screening for Heart Attack Prevention and Education Task Force recommendations to an urban population: observations from the Dallas Heart Study.
Archives of internal medicine 2008;168(10):1055-62.
2008: Scott M Grundy
Metabolic syndrome pandemic.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(4):629-36.
2008: Manjinder S Sandhu; Dawn M Waterworth; Sally L Debenham; Eleanor Wheeler; Konstantinos Papadakis; Jing Hua Zhao; Kijoung Song; Xin Yuan; Toby Johnson; Sofie Ashford; Michael Inouye; Robert Luben; Matthew Sims; David Hadley; Wendy L McArdle; Philip Barter; Y Antero Kesäniemi; Robert W Mahley; Ruth McPherson; Scott M Grundy; Sheila A Bingham; Kay-Tee Khaw; Ruth J F Loos; Gérard Waeber; Inês Barroso; David P Strachan; Panos Deloukas; Peter Vollenweider; Nicholas J Wareham; Vincent Mooser
LDL-cholesterol concentrations: a genome-wide association study.
Lancet 2008;371(9611):483-91.
2008: Scott M Grundy
Promise of low-density lipoprotein-lowering therapy for primary and secondary prevention.
Circulation 2008;117(4):569-73; discussion 573.
2008: Scott M Grundy
Thyroid mimetic as an option for lowering low-density lipoprotein.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(2):409-10.
2007: Meena Shah; Beverley Adams-Huet; Linda J Brinkley; Scott M Grundy; Abhimanyu Garg
Lipid, glycemic, and insulin responses to meals rich in saturated, cis-monounsaturated, and polyunsaturated (n-3 and n-6) fatty acids in subjects with type 2 diabetes.
Diabetes care 2007;30(12):2993-8.
2007: Shuaib M Abdullah; Amit Khera; David Leonard; Sandeep R Das; Russell M Canham; Sandeep A Kamath; Gloria Lena Vega; Scott M Grundy; Darren K McGuire; James A de Lemos
Sex differences in the association between leptin and CRP: results from the Dallas Heart Study.
Atherosclerosis 2007;195(2):404-10.
2007: Philip J Barter; Mark Caulfield; Mats Eriksson; Scott M Grundy; John J P Kastelein; Michel Komajda; Jose Lopez-Sendon; Lori Mosca; Jean-Claude Tardif; David D Waters; Charles L Shear; James H Revkin; Kevin A Buhr; Marian R Fisher; Alan R Tall; Bryan Brewer
Effects of torcetrapib in patients at high risk for coronary events.
The New England journal of medicine 2007;357(21):2109-22.
2007: Philip J Barter; Antonio M Gotto; John C LaRosa; Jaman Maroni; Michael Szarek; Scott M Grundy; John J P Kastelein; Vera Bittner; Jean-Charles Fruchart
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.
The New England journal of medicine 2007;357(13):1301-10.
2007: Scott M Grundy
Cardiovascular and metabolic risk factors: how can we improve outcomes in the high-risk patient?
The American journal of medicine 2007;120(9 Suppl 1):S3-8; discussion S9.
2007: John C LaRosa; Scott M Grundy; John J P Kastelein; John B Kostis; Heiner Greten
Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).
The American journal of cardiology 2007;100(5):747-52.
2007: Gloria Lena Vega; Manisha Chandalia; Lidia S Szczepaniak; Scott M Grundy
Metabolic correlates of nonalcoholic fatty liver in women and men.
Hepatology (Baltimore, Md.) 2007;46(3):716-22.
2007: Raphael See; Shuaib M Abdullah; Darren K McGuire; Amit Khera; Mahesh J Patel; Jason B Lindsey; Scott M Grundy; James A de Lemos
The association of differing measures of overweight and obesity with prevalent atherosclerosis: the Dallas Heart Study.
Journal of the American College of Cardiology 2007;50(8):752-9.
2007: Philip J Barter; Y Ruth McPherson; Kijoung Song; Y Antero Kesäniemi; Robert W Mahley; Gérard Waeber; Thomas P Bersot; Vincent Mooser; Dawn M Waterworth; Scott M Grundy
Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia.
The Journal of clinical endocrinology and metabolism 2007;92(6):2041-5.
2007: Scott M Grundy
Should women be offered cholesterol lowering drugs to prevent cardiovascular disease? Yes.
BMJ (Clinical research ed.) 2007;334(7601):982.
2007: Manisha Chandalia; Scott M Grundy; Beverley Adams-Huet; Nicola Abate
Ethnic differences in the frequency of ENPP1/PC1 121Q genetic variant in the Dallas Heart Study cohort.
Journal of diabetes and its complications 2007;21(3):143-8.
2007: Gerd Assmann; Rudy Guerra; Garrett Fox; Paul Cullen; Helmut Schulte; DuWayne Willett; Scott M Grundy
Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations.
The American journal of cardiology 2007;99(4):541-8.
2007: Scott M Grundy
Metabolic syndrome: a multiplex cardiovascular risk factor.
The Journal of clinical endocrinology and metabolism 2007;92(2):399-404.
2007: Craig Chang; Ana Barbara Garcia-Garcia; Elizabeth Hamilton; Brijen Shah; Shinichi Meguro; Scott M Grundy; David A Provost; Gloria Lena Vega
Metabolic syndrome phenotype in very obese women.
Metabolic syndrome and related disorders 2007;5(1):3-12.
2007: Manisha Chandalia; Ping Lin; Thanalakshmi Seenivasan; Edward H Livingston; Peter G Snell; Scott M Grundy; Nicola Abate
Insulin resistance and body fat distribution in South Asian men compared to Caucasian men.
PloS one 2007;2(8):e812.
2006: Nicola Abate; Manisha Chandalia; Rosa Di Paola; Daniel W Foster; Scott M Grundy; Vincenzo Trischitta
Mechanisms of disease: Ectonucleotide pyrophosphatase phosphodiesterase 1 as a 'gatekeeper' of insulin receptors.
Nature clinical practice. Endocrinology & metabolism 2006;2(12):694-701.
2006: David D Waters; John C LaRosa; Philip J Barter; Jean-Charles Fruchart; Antonio M Gotto; Roddy Carter; Andrei Breazna; John J P Kastelein; Scott M Grundy
Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) study.
Journal of the American College of Cardiology 2006;48(9):1793-9.
2006: Gloria Lena Vega; Beverley Adams-Huet; ronald peshock; DuWayne Willett; Brijen Shah; Scott M Grundy
Influence of body fat content and distribution on variation in metabolic risk.
The Journal of clinical endocrinology and metabolism 2006;91(11):4459-66.
2006: Prakash Deedwania; Philip J Barter; Rafael Carmena; Jean-Charles Fruchart; Scott M Grundy; Steven M Haffner; John J P Kastelein; John C LaRosa; Holly Schachner; James Shepherd; David D Waters
Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study.
Lancet 2006;368(9539):919-28.
2006: Scott M Grundy
Does the metabolic syndrome exist?
Diabetes care 2006;29(7):1689-92; discussion 1693-6.
2006: Scott M Grundy
Does a diagnosis of metabolic syndrome have value in clinical practice?
The American journal of clinical nutrition 2006;83(6):1248-51.
2006: Venkatesan Radha; Karani Santhanakrishnan Vimaleswaran; Hunsur Narayan S Babu; Nicola Abate; Manisha Chandalia; Pankaj Satija; Scott M Grundy; Saurabh Ghosh; Partha P Majumder; Raj Deepa; Sathyanarayana M R Rao; Viswanathan Mohan
Role of genetic polymorphism peroxisome proliferator-activated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: Evidence for heterogeneity.
Diabetes care 2006;29(5):1046-51.
2006: Scott M Grundy
Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy.
Nature reviews. Drug discovery 2006;5(4):295-309.
2006: Scott M Grundy
Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds.
Journal of the American College of Cardiology 2006;47(6):1093-100.
2006: Jonathan C Cohen; Alexander Pertsemlidis; Saleemah Fahmi; Sophie Esmail; Gloria Lena Vega; Scott M Grundy; Helen H Hobbs
Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(6):1810-5.
2006: Amit Khera; James A de Lemos; ronald peshock; Hao S Lo; Harold G Stanek; Sabina A Murphy; Frank H Wians; Scott M Grundy; Darren K McGuire
Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study.
Circulation 2006;113(1):38-43.
2006: Scott M Grundy
Atherogenic dyslipidemia associated with metabolic syndrome and insulin resistance.
Clinical cornerstone 2006;8 Suppl 1():S21-7.
2005: Yi Yu; Diego F Wyszynski; Dawn M Waterworth; Steven D Wilton; Philip J Barter; Y Antero Kesäniemi; Robert W Mahley; Ruth McPherson; Gérard Waeber; Thomas P Bersot; Qianli Ma; Sanjay S Sharma; Douglas S Montgomery; Lefkos T Middleton; Scott S Sundseth; Vincent Mooser; Scott M Grundy; Lindsay A Farrer
Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia.
Journal of lipid research 2005;46(10):2202-13.
2005: Amit Khera; Darren K McGuire; Sabina A Murphy; Harold G Stanek; Sandeep R Das; Wanpen Vongpatanasin; Frank H Wians; Scott M Grundy; James A de Lemos
Race and gender differences in C-reactive protein levels.
Journal of the American College of Cardiology 2005;46(3):464-9.
2005: Scott M Grundy
Point: the metabolic syndrome still lives.
Clinical chemistry 2005;51(8):1352-4.
2005: Scott M Grundy
Stanol esters as a component of maximal dietary therapy in the National Cholesterol Education Program Adult Treatment Panel III report.
The American journal of cardiology 2005;96(1A):47D-50D.
2005: Nilo B Cater; Ana Barbara Garcia-Garcia; Gloria Lena Vega; Scott M Grundy
Responsiveness of plasma lipids and lipoproteins to plant stanol esters.
The American journal of cardiology 2005;96(1A):23D-28D.
2005: Gloria Lena Vega; Nilo B Cater; Shinichi Meguro; Scott M Grundy
Influence of extended-release nicotinic acid on nonesterified fatty acid flux in the metabolic syndrome with atherogenic dyslipidemia.
The American journal of cardiology 2005;95(11):1309-13.
2005: John C LaRosa; Scott M Grundy; David D Waters; Charles L Shear; Philip J Barter; Jean-Charles Fruchart; Antonio M Gotto; Heiner Greten; John J P Kastelein; James Shepherd; Nanette K Wenger
Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
The New England journal of medicine 2005;352(14):1425-35.
2005: Nicola Abate; Manisha Chandalia; Pankaj Satija; Beverley Adams-Huet; Scott M Grundy; Sreedharan Sandeep; Venkatesan Radha; Raj Deepa; Viswanathan Mohan
ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes.
Diabetes 2005;54(4):1207-13.
2005: Diego F Wyszynski; Dawn M Waterworth; Philip J Barter; Jonathan Cohen; Y Antero Kesäniemi; Robert W Mahley; Ruth McPherson; Gérard Waeber; Thomas P Bersot; Sanjay S Sharma; Vikki G Nolan; Lefkos T Middleton; Scott S Sundseth; Lindsay A Farrer; Vincent Mooser; Scott M Grundy
Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project).
The American journal of cardiology 2005;95(2):194-8.
2005: Scott M Grundy
Metabolic syndrome: therapeutic considerations.
Handbook of experimental pharmacology 2005;(170):107-33.
2005: Scott M Grundy
A constellation of complications: the metabolic syndrome.
Clinical cornerstone 2005;7(2-3):36-45.
2004: Jeffrey D Browning; Lidia S Szczepaniak; Robert L Dobbins; Pamela Nuremberg; Jay D Horton; Jonathan C Cohen; Scott M Grundy; Helen H Hobbs
Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.
Hepatology (Baltimore, Md.) 2004;40(6):1387-95.
2004: Kenneth R Wilund; Liqing Yu; Fang Xu; Gloria Lena Vega; Scott M Grundy; Jonathan C Cohen; Helen H Hobbs
No association between plasma levels of plant sterols and atherosclerosis in mice and men.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(12):2326-32.
2004: Tulika Jain; ronald peshock; Darren K McGuire; DuWayne Willett; Zhoaxia Yu; Zhoazia Yu; Gloria Lena Vega; Rudy Guerra; Helen H Hobbs; Scott M Grundy
African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study.
Journal of the American College of Cardiology 2004;44(5):1011-7.
2004: Scott M Grundy
Metabolic syndrome: part II.
Endocrinology and metabolism clinics of North America 2004;33(3):xi-xiii.
2004: Nicola Abate; Manisha Chandalia; Peter G Snell; Scott M Grundy
Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men.
The Journal of clinical endocrinology and metabolism 2004;89(6):2750-5.
2004: Scott M Grundy
Obesity, metabolic syndrome, and cardiovascular disease.
The Journal of clinical endocrinology and metabolism 2004;89(6):2595-600.
2004: Scott M Grundy
Metabolic syndrome: part I.
Endocrinology and metabolism clinics of North America 2004;33(2):ix-xi.
2004: Scott M Grundy
What is the contribution of obesity to the metabolic syndrome?
Endocrinology and metabolism clinics of North America 2004;33(2):267-82, table of contents.
2003: Nicola Abate; Lucia Carulli; Alberto V Cabo-Chan; Manisha Chandalia; Peter G Snell; Scott M Grundy
Genetic polymorphism PC-1 K121Q and ethnic susceptibility to insulin resistance.
The Journal of clinical endocrinology and metabolism 2003;88(12):5927-34.
2003: Scott M Grundy
Atherosclerosis imaging for risk assessment and primary prevention of cardiovascular disease.
Progress in cardiovascular diseases 2003;46(2):115-21.
2003: Gloria Lena Vega; Nilo B Cater; Dariusch R Hadizadeh; Shinichi Meguro; Scott M Grundy
Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome.
Clinical pharmacology and therapeutics 2003;74(3):236-44.
2003: Manisha Chandalia; Alberto V Cabo-Chan; Sridevi Devaraj; Ishwarlal Jialal; Scott M Grundy; Nicola Abate
Elevated plasma high-sensitivity C-reactive protein concentrations in Asian Indians living in the United States.
The Journal of clinical endocrinology and metabolism 2003;88(8):3773-6.
2003: Gloria Lena Vega; Patrick T S Ma; Nilo B Cater; Neil Filipchuk; Shinichi Meguro; Ana Barbara Garcia-Garcia; Scott M Grundy
Effects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined hyperlipidemia and metabolic syndrome.
The American journal of cardiology 2003;91(8):956-60.
2003: Manisha Chandalia; Nicola Abate; Alberto V Cabo-Chan; Sridevi Devaraj; Ishwarlal Jialal; Scott M Grundy
Hyperhomocysteinemia in Asian Indians living in the United States.
The Journal of clinical endocrinology and metabolism 2003;88(3):1089-95.
2002: Scott M Grundy; Nicola Abate; Manisha Chandalia
Diet composition and the metabolic syndrome: what is the optimal fat intake?
The American journal of medicine 2002;113 Suppl 9B():25S-29S.
2002: Surekha Mathur; Sridevi Devaraj; Scott M Grundy; Ishwarlal Jialal
Cocoa products decrease low density lipoprotein oxidative susceptibility but do not affect biomarkers of inflammation in humans.
The Journal of nutrition 2002;132(12):3663-7.
2002: Dawn J O'Byrne; Sridevi Devaraj; Scott M Grundy; Ishwarlal Jialal
Comparison of the antioxidant effects of Concord grape juice flavonoids alpha-tocopherol on markers of oxidative stress in healthy adults.
The American journal of clinical nutrition 2002;76(6):1367-74.
2002: Scott M Grundy
Alternative approaches to cholesterol-lowering therapy.
The American journal of cardiology 2002;90(10):1135-8.
2002: Scott M Grundy
Approach to lipoprotein management in 2001 National Cholesterol Guidelines.
The American journal of cardiology 2002;90(8A):11i-21i.
2002: Nicola Abate; Steven M Haffner; Abhimanyu Garg; ronald peshock; Scott M Grundy
Sex steroid hormones, upper body obesity, and insulin resistance.
The Journal of clinical endocrinology and metabolism 2002;87(10):4522-7.
2002: Scott M Grundy; Gloria Lena Vega; Mark E McGovern; Brian R Tulloch; David M Kendall; David Fitz-Patrick; Om P Ganda; Robert S Rosenson; John B Buse; David D Robertson; John P Sheehan
Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial.
Archives of internal medicine 2002;162(14):1568-76.
2002: Ralph V Shohet; Gloria Lena Vega; Thomas P Bersot; Robert W Mahley; Scott M Grundy; Rudy Guerra; Jonathan C Cohen
Sources of variability in genetic association studies: insights from the analysis of hepatic lipase (LIPC).
Human mutation 2002;19(5):536-42.
2002: Knut E Berge; Klaus Von Bergmann; Dieter Lutjohann; Rudy Guerra; Scott M Grundy; Helen H Hobbs; Jonathan C Cohen
Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8.
Journal of lipid research 2002;43(3):486-94.
2001: Scott M Grundy
United States Cholesterol Guidelines 2001: expanded scope of intensive low-density lipoprotein-lowering therapy.
The American journal of cardiology 2001;88(7B):23J-27J.
2001: Scott M Grundy; R B D'Agostino Sr; L Mosca; G L Burke; P W Wilson; D J Rader; J I Cleeman; Edward J Roccella; J A Cutler; L M Friedman
Cardiovascular risk assessment based on US cohort studies: findings from a National Heart, Lung, and Blood institute workshop.
Circulation 2001;104(4):491-6.
2001: Scott M Grundy
Coronary plaque as a replacement for age as a risk factor in global risk assessment.
The American journal of cardiology 2001;88(2A):8E-11E.
2001: Lisiane Meira; Sridevi Devaraj; Glen E Kisby; Dennis K Burns; R L Daniel; RE Hammer; Scott M Grundy; Ishwarlal Jialal; Errol C Friedberg
Heterozygosity for the mouse Apex gene results in phenotypes associated with oxidative stress.
Cancer research 2001;61(14):5552-7.
2001: N Kaul; Sridevi Devaraj; Scott M Grundy; Ishwarlal Jialal
Failure to demonstrate a major anti-inflammatory effect with alpha tocopherol supplementation (400 IU/day) in normal subjects.
The American journal of cardiology 2001;87(11):1320-3.
2001: Ishwarlal Jialal; Daniel Stein; D Balis; Scott M Grundy; Beverley Adams-Huet; Sridevi Devaraj
Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels.
Circulation 2001;103(15):1933-5.
2001: Dawn J O'Byrne; Sridevi Devaraj; Kazi Nazrul Islam; R Collazo; L McDonald; Scott M Grundy; Ishwarlal Jialal
Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy.
Metabolism: clinical and experimental 2001;50(2):207-15.
2000: Dawn J O'Byrne; Scott M Grundy; L Packer; Sridevi Devaraj; K Baldenius; Peter P Hoppe; Klaus Kraemer; Ishwarlal Jialal; M G Traber
Studies of LDL oxidation following alpha-, gamma-, or delta-tocotrienyl acetate supplementation of hypercholesterolemic humans.
Free radical biology & medicine 2000;29(9):834-45.
2000: Manisha Chandalia; Abhimanyu Garg; Dieter Lutjohann; Klaus Von Bergmann; Scott M Grundy; Linda J Brinkley
Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus.
The New England journal of medicine 2000;342(19):1392-8.
2000: Kazi Nazrul Islam; Dawn J O'Byrne; Sridevi Devaraj; B Palmer; Scott M Grundy; Ishwarlal Jialal
Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy.
Atherosclerosis 2000;150(1):217-24.
2000: Scott M Grundy
Cholesterol management in the era of managed care.
The American journal of cardiology 2000;85(3A):3A-9A.
2000: Robert D Toto; Scott M Grundy; Gloria Lena Vega
Pravastatin treatment of very low density, intermediate density and low density lipoproteins in hypercholesterolemia and combined hyperlipidemia secondary to the nephrotic syndrome.
American journal of nephrology 2000;20(1):12-7.
1999: Scott M Grundy
Primary prevention of coronary heart disease: integrating risk assessment with intervention.
Circulation 1999;100(9):988-98.
1999: Scott M Grundy
Primary prevention of coronary heart disease: selection of patients for aggressive cholesterol management.
The American journal of medicine 1999;107(2A):2S-6S.
1999: Ralph V Shohet; Gloria Lena Vega; A Anwar; Joaquin E Cigarroa; Scott M Grundy; Jonathan C Cohen
Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(8):1975-8.
1999: Gloria Lena Vega; Klaus Von Bergmann; Scott M Grundy; S Blumenschein; N B Carter; P Laeis; B Lindenthal; J von Bergmann; A Simatupang; Dieter Lutjohann; Beverley Adams-Huet
Effect of lifibrol on the metabolism of low density lipoproteins and cholesterol.
Journal of internal medicine 1999;246(1):1-9.
1999: Manisha Chandalia; Nicola Abate; Abhimanyu Garg; James Stray-Gundersen; Scott M Grundy
Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men.
The Journal of clinical endocrinology and metabolism 1999;84(7):2329-35.
1999: Scott M Grundy
Hypertriglyceridemia, insulin resistance, and the metabolic syndrome.
The American journal of cardiology 1999;83(9B):25F-29F.
1999: Thomas P Bersot; Gloria Lena Vega; Scott M Grundy; K Erhan Palaoglu; P Atagündüz; Sinan Ozbayrakçi; O Gökdemir; Robert W Mahley
Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population.
Journal of lipid research 1999;40(3):432-8.
1999: Scott M Grundy; Gloria Lena Vega; J D Otvos; David L Rainwater; Jonathan C Cohen
Hepatic lipase activity influences high density lipoprotein subclass distribution in normotriglyceridemic men. Genetic and pharmacological evidence.
Journal of lipid research 1999;40(2):229-34.
1998: Scott M Grundy
Cholesterol management in high-risk patients without heart disease. When is lipid-lowering medication warranted for primary prevention?
Postgraduate medicine 1998;104(5):117-20, 123-4, 129.
1998: Scott M Grundy
The role of cholesterol management in coronary disease risk reduction in elderly patients.
Endocrinology and metabolism clinics of North America 1998;27(3):655-75, x.
1998: L Nie; S Niu; Gloria Lena Vega; Luther Clark; A Tang; Scott M Grundy; Jonathan C Cohen
Three polymorphisms associated with low hepatic lipase activity are common in African Americans.
Journal of lipid research 1998;39(9):1900-3.
1998: Shailendra Patel; G Salen; H Hidaka; Peter O Kwiterovich; A F Stalenhoef; T A Miettinen; Scott M Grundy; M H Lee; J S Rubenstein; Mihael H Polymeropoulos; M J Brownstein
Mapping a gene involved in regulating dietary cholesterol absorption. The sitosterolemia locus is found at chromosome 2p21.
The Journal of clinical investigation 1998;102(5):1041-4.
1998: Gloria Lena Vega; J Gao; Thomas P Bersot; Robert W Mahley; R Verstraete; Scott M Grundy; A White; Jonathan C Cohen
The -514 polymorphism in the hepatic lipase gene (LIPC) does not influence androgen-mediated stimulation of hepatic lipase activity.
Journal of lipid research 1998;39(7):1520-4.
1998: Sridevi Devaraj; G Vega; Richard A Lange; Scott M Grundy; Ishwarlal Jialal
Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease.
The American journal of medicine 1998;104(5):445-50.
1998: L Nie; Jin Wang; Luther Clark; A Tang; Gloria Lena Vega; Scott M Grundy; Jonathan C Cohen
Body mass index and hepatic lipase gene (LIPC) polymorphism jointly influence postheparin plasma hepatic lipase activity.
Journal of lipid research 1998;39(5):1127-30.
1998: J M Mostaza; Gloria Lena Vega; P Snell; Scott M Grundy
Abnormal metabolism of free fatty acids in hypertriglyceridaemic men: apparent insulin resistance of adipose tissue.
Journal of internal medicine 1998;243(4):265-74.
1998: F Tatò; Gloria Lena Vega; Scott M Grundy
Effects of crystalline nicotinic acid-induced hepatic dysfunction on serum low-density lipoprotein cholesterol and lecithin cholesteryl acyl transferase.
The American journal of cardiology 1998;81(6):805-7.
1998: Scott M Grundy
Multifactorial causation of obesity: implications for prevention.
The American journal of clinical nutrition 1998;67(3 Suppl):563S-72S.
1998: Gloria Lena Vega; Scott M Grundy
Effect of statins on metabolism of apo-B-containing lipoproteins in hypertriglyceridemic men.
The American journal of cardiology 1998;81(4A):36B-42B.
1998: Scott M Grundy
Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome.
The American journal of cardiology 1998;81(4A):18B-25B.
1998: Scott M Grundy
Consensus statement: Role of therapy with "statins" in patients with hypertriglyceridemia.
The American journal of cardiology 1998;81(4A):1B-6B.
1998: Gloria Lena Vega; Luther Clark; A Tang; S Marcovina; Scott M Grundy; Jonathan C Cohen
Hepatic lipase activity is lower in African American men than in white American men: effects of 5' flanking polymorphism in the hepatic lipase gene (LIPC).
Journal of lipid research 1998;39(1):228-32.
1997: Scott M Grundy
What is the desirable ratio of saturated, polyunsaturated, and monounsaturated fatty acids in the diet?
The American journal of clinical nutrition 1997;66(4 Suppl):988S-990S.
1997: A Nemeth-Slany; P Talmud; Scott M Grundy; Shailendra Patel
Activation of a cryptic splice-site in intron 24 leads to the formation of apolipoprotein B-27.6.
Atherosclerosis 1997;133(2):163-70.
1997: Scott M Grundy
Cholesterol management in patients with heart disease. Emphasizing secondary prevention to increase longevity.
Postgraduate medicine 1997;102(2):81-4, 87-90.
1997: X Li; Scott M Grundy; Shailendra Patel
Obesity in db and ob animals leads to impaired hepatic very low density lipoprotein secretion and differential secretion of apolipoprotein B-48 and B-100.
Journal of lipid research 1997;38(7):1277-88.
1997: Scott M Grundy
Cholesterol and coronary heart disease. The 21st century.
Archives of internal medicine 1997;157(11):1177-84.
1997: J M Mostaza; I Schulz; Gloria Lena Vega; Scott M Grundy
Comparison of pravastatin with crystalline nicotinic acid monotherapy in treatment of combined hyperlipidemia.
The American journal of cardiology 1997;79(9):1298-301.
1997: Rudy Guerra; Jin Wang; Scott M Grundy; Jonathan C Cohen
A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(9):4532-7.
1997: Scott M Grundy
Primary prevention of coronary heart disease: role of cholesterol control in the United States.
Journal of internal medicine 1997;241(4):295-306.
1997: Scott M Grundy
Cholesterol issues as viewed from the United States.
Journal of internal medicine 1997;241(4):279-81.
1997: A Misra; Abhimanyu Garg; Nicola Abate; ronald peshock; James Stray-Gundersen; Scott M Grundy
Relationship of anterior and posterior subcutaneous abdominal fat to insulin sensitivity in nondiabetic men.
Obesity research 1997;5(2):93-9.
1997: Scott M Grundy
Management of high serum cholesterol and related disorders in patients at risk for coronary heart disease.
The American journal of medicine 1997;102(2A):15-22.
1997: Nicola Abate; Abhimanyu Garg; R Coleman; Scott M Grundy; ronald peshock
Prediction of total subcutaneous abdominal, intraperitoneal, and retroperitoneal adipose tissue masses in men by a single axial magnetic resonance imaging slice.
The American journal of clinical nutrition 1997;65(2):403-8.
1997: F Tato; Gloria Lena Vega; Scott M Grundy
Determinants of plasma HDL-cholesterol in hypertriglyceridemic patients. Role of cholesterol-ester transfer protein and lecithin cholesteryl acyl transferase.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(1):56-63.
1996: Nicola Abate; Abhimanyu Garg; ronald peshock; James Stray-Gundersen; Beverley Adams-Huet; Scott M Grundy
Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM.
Diabetes 1996;45(12):1684-93.
1996: Shailendra Patel; Scott M Grundy
Interactions between microsomal triglyceride transfer protein and apolipoprotein B within the endoplasmic reticulum in a heterologous expression system.
The Journal of biological chemistry 1996;271(31):18686-94.
1996: Gloria Lena Vega; Scott M Grundy
Hypoalphalipoproteinemia (low high density lipoprotein) as a risk factor for coronary heart disease.
Current opinion in lipidology 1996;7(4):209-16.
1996: R McPherson; Scott M Grundy; Rudy Guerra; Jonathan C Cohen
Allelic variation in the gene encoding the cholesteryl ester transfer protein is associated with variation in the plasma concentrations of cholesteryl ester transfer protein.
Journal of lipid research 1996;37(8):1743-8.
1996: Scott M Grundy; Ernest Mazzaferri
Addressing the spectrum of hypercholesterolemia.
Hospital practice (1995) 1996;31(6):43-8, 53-5, 59; discussion 60.
1996: R Martin-Jadraque; F Tato; J M Mostaza; Gloria Lena Vega; Scott M Grundy
Effectiveness of low-dose crystalline nicotinic acid in men with low high-density lipoprotein cholesterol levels.
Archives of internal medicine 1996;156(10):1081-8.
1996: C J Fuller; M Chandalia; Abhimanyu Garg; Scott M Grundy; Ishwarlal Jialal
RRR-alpha-tocopheryl acetate supplementation at pharmacologic doses decreases low-density-lipoprotein oxidative susceptibility but not protein glycation in patients with diabetes mellitus.
The American journal of clinical nutrition 1996;63(5):753-9.
1996: Gloria Lena Vega; Scott M Grundy
Hypercholesterolemia with cholesterol-enriched LDL and normal levels of LDL-apolipoprotein B. Effects of the step I diet and bile acid sequestrants on the cholesterol content of LDL.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(4):517-22.
1996: C J Fuller; Scott M Grundy; E P Norkus; Ishwarlal Jialal
Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers.
Atherosclerosis 1996;119(2):139-50.
1996: Gloria Lena Vega; Scott M Grundy
Quantitation of apolipoprotein B by chemical methods.
Methods in enzymology 1996;263():63-82.
1995: Nicola Abate; Gloria Lena Vega; Abhimanyu Garg; Scott M Grundy
Abnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM.
Atherosclerosis 1995;118(1):111-22.
1995: Shailendra Patel; Scott M Grundy
Heterologous expression of apolipoprotein B carboxyl-terminal truncates: a model for the study of lipoprotein biogenesis.
Journal of lipid research 1995;36(10):2090-103.
1995: Nicola Abate; Abhimanyu Garg; ronald peshock; James Stray-Gundersen; Scott M Grundy
Relationships of generalized and regional adiposity to insulin sensitivity in men.
The Journal of clinical investigation 1995;96(1):88-98.
1995: B U Tezabwala; Michael Bennett; Scott M Grundy
Immunotoxicity of polyunsaturated fatty acids in serum-free medium.
Immunopharmacology and immunotoxicology 1995;17(2):365-83.
1995: F Tato; Gloria Lena Vega; Scott M Grundy
Bimodal distribution of cholesteryl ester transfer protein activities in normotriglyceridemic men with low HDL cholesterol concentrations.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(4):446-51.
1995: Margo A Denke; Scott M Grundy
Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia.
Archives of internal medicine 1995;155(4):393-9.
1995: Scott M Grundy
Atherogenic dyslipidemia: lipoprotein abnormalities and implications for therapy.
The American journal of cardiology 1995;75(6):45B-52B.
1995: Gloria Lena Vega; Robert D Toto; Scott M Grundy
Metabolism of low density lipoproteins in nephrotic dyslipidemia: comparison of hypercholesterolemia alone and combined hyperlipidemia.
Kidney international 1995;47(2):579-86.
1994: Jonathan C Cohen; Z Wang; Scott M Grundy; M R Stoesz; Rudy Guerra
Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels.
The Journal of clinical investigation 1994;94(6):2377-84.
1994: Scott M Grundy
Influence of stearic acid on cholesterol metabolism relative to other long-chain fatty acids.
The American journal of clinical nutrition 1994;60(6 Suppl):986S-990S.
1994: A Garg; Scott M Grundy
Cholestyramine therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. A short-term, double-blind, crossover trial.
Annals of internal medicine 1994;121(6):416-22.
1994: Nicola Abate; D Burns; ronald peshock; Abhimanyu Garg; Scott M Grundy
Estimation of adipose tissue mass by magnetic resonance imaging: validation against dissection in human cadavers.
Journal of lipid research 1994;35(8):1490-6.
1994: Abhimanyu Garg; J P Bantle; R R Henry; Ann Coulston; K A Griver; S K Raatz; L Brinkley; Y D Chen; Scott M Grundy; B A Huet
Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitus.
JAMA : the journal of the American Medical Association 1994;271(18):1421-8.
1994: A Montali; Gloria Lena Vega; Scott M Grundy
Concentrations of apolipoprotein A-I-containing particles in patients with hypoalphalipoproteinemia.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(4):511-7.
1994: Margo A Denke; C T Sempos; Scott M Grundy
Excess body weight. An under-recognized contributor to dyslipidemia in white American women.
Archives of internal medicine 1994;154(4):401-10.
1994: Margo A Denke; Scott M Grundy
Individual responses to a cholesterol-lowering diet in 50 men with moderate hypercholesterolemia.
Archives of internal medicine 1994;154(3):317-25.
1994: M Arca; Gloria Lena Vega; Scott M Grundy
Hypercholesterolemia in postmenopausal women. Metabolic defects and response to low-dose lovastatin.
JAMA : the journal of the American Medical Association 1994;271(6):453-9.
1994: Gloria Lena Vega; Scott M Grundy
Lipoprotein responses to treatment with lovastatin, gemfibrozil, and nicotinic acid in normolipidemic patients with hypoalphalipoproteinemia.
Archives of internal medicine 1994;154(1):73-82.
1994: W G Abbott; B Tezabwala; Michael Bennett; Scott M Grundy
Melanoma lung metastases and cytolytic effector cells in mice fed antioxidant-balanced corn oil or fish oil diets.
Natural immunity 1994;13(1):15-28.
1993: Ishwarlal Jialal; Scott M Grundy
Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation.
Circulation 1993;88(6):2780-6.
1993: Nicola Abate; Gloria Lena Vega; Scott M Grundy
Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein B-100.
Atherosclerosis 1993;104(1-2):159-71.
1993: Robert D Toto; Gloria Lena Vega; Scott M Grundy
Mechanisms and treatment of dyslipidemia of renal diseases.
Current opinion in nephrology and hypertension 1993;2(5):784-90.
1993: B Blades; Gloria Lena Vega; Scott M Grundy
Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(8):1227-35.
1993: Margo A Denke; C T Sempos; Scott M Grundy
Excess body weight. An underrecognized contributor to high blood cholesterol levels in white American men.
Archives of internal medicine 1993;153(9):1093-103.
1993: Scott M Grundy
Oxidized LDL and atherogenesis: relation to risk factors for coronary heart disease.
Clinical cardiology 1993;16(4 Suppl 1):I3-5.
1993: Gloria Lena Vega; Scott M Grundy
Two patterns of LDL metabolism in normotriglyceridemic patients with hypoalphalipoproteinemia.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(4):579-89.
1992: Scott M Grundy
Cholesterol-lowering drugs as cardioprotective agents.
The American journal of cardiology 1992;70(21):27I-32I.
1992: Gloria Lena Vega; Scott M Grundy
Occurrence of species of low-density lipoprotein with defective clearance in patients with primary moderate hypercholesterolaemia.
Journal of internal medicine 1992;232(5):405-13.
1992: L S Cristol; Ishwarlal Jialal; Scott M Grundy
Effect of low-dose probucol therapy on LDL oxidation and the plasma lipoprotein profile in male volunteers.
Atherosclerosis 1992;97(1):11-20.
1992: Margo A Denke; Scott M Grundy
Comparison of effects of lauric acid and palmitic acid on plasma lipids and lipoproteins.
The American journal of clinical nutrition 1992;56(5):895-8.
1992: H Gylling; Gloria Lena Vega; Scott M Grundy
Physiologic mechanisms for reduced apolipoprotein A-I concentrations associated with low levels of high density lipoprotein cholesterol in patients with normal plasma lipids.
Journal of lipid research 1992;33(10):1527-39.
1992: Abhimanyu Garg; Scott M Grundy; Roger H Unger
Comparison of effects of high and low carbohydrate diets on plasma lipoproteins and insulin sensitivity in patients with mild NIDDM.
Diabetes 1992;41(10):1278-85.
1992: Ishwarlal Jialal; Scott M Grundy
Influence of antioxidant vitamins on LDL oxidation.
Annals of the New York Academy of Sciences 1992;669():237-47; discussion 247-8.
1992: Abhimanyu Garg; James L Fleckenstein; ronald peshock; Scott M Grundy
Peculiar distribution of adipose tissue in patients with congenital generalized lipodystrophy.
The Journal of clinical endocrinology and metabolism 1992;75(2):358-61.
1992: M A Wilson; Gloria Lena Vega; H Gylling; Scott M Grundy
Persistence of abnormalities in metabolism of apolipoproteins B-100 and A-I after weight reduction in patients with primary hypertriglyceridemia.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1992;12(8):976-84.
1992: J C Cohen; Scott M Grundy
Normal postprandial lipemia in men with low plasma HDL concentrations.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1992;12(8):972-5.
1992: Andrea Bonanome; M Bennett; Scott M Grundy
Metabolic effects of dietary stearic acid in mice: changes in the fatty acid composition of triglycerides and phospholipids in various tissues.
Atherosclerosis 1992;94(2-3):119-27.
1992: Ishwarlal Jialal; Scott M Grundy
Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein.
Journal of lipid research 1992;33(6):899-906.
1992: Scott M Grundy; Gloria Lena Vega
Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Implications for treatment.
Archives of internal medicine 1992;152(1):28-34.
1991: Margo A Denke; Scott M Grundy
Effects of fats high in stearic acid on lipid and lipoprotein concentrations in men.
The American journal of clinical nutrition 1991;54(6):1036-40.
1991: Scott M Grundy
George Lyman Duff Memorial Lecture. Multifactorial etiology of hypercholesterolemia. Implications for prevention of coronary heart disease.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1991;11(6):1619-35.
1991: Ishwarlal Jialal; E P Norkus; L Cristol; Scott M Grundy
beta-Carotene inhibits the oxidative modification of low-density lipoprotein.
Biochimica et biophysica acta 1991;1086(1):134-8.
1991: Scott M Grundy
Hypertriglyceridemia. Examining its role in coronary heart disease.
Postgraduate medicine 1991;90(5):201-2, 207-10.
1991: Gloria Lena Vega; Scott M Grundy
Influence of lovastatin therapy on metabolism of low density lipoproteins in mixed hyperlipidaemia.
Journal of internal medicine 1991;230(4):341-50.
1991: J C Cohen; James Stray-Gundersen; Scott M Grundy
Dissociation between postprandial lipemia and high density lipoprotein cholesterol concentrations in endurance-trained men.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1991;11(4):838-43.
1991: Gloria Lena Vega; Margo A Denke; Scott M Grundy
Metabolic basis of primary hypercholesterolemia.
Circulation 1991;84(1):118-28.
1991: Gloria Lena Vega; Helen H Hobbs; Scott M Grundy
Low density lipoprotein kinetics in a family having defective low density lipoprotein receptors in which hypercholesterolemia is suppressed.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1991;11(3):578-85.
1991: Ishwarlal Jialal; D A Freeman; Scott M Grundy
Varying susceptibility of different low density lipoproteins to oxidative modification.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1991;11(3):482-8.
1991: Gloria Lena Vega; H Gylling; A V Nichols; Scott M Grundy
Evaluation of a method for study of kinetics of autologous apolipoprotein A-I.
Journal of lipid research 1991;32(5):867-75.
1991: Ishwarlal Jialal; Scott M Grundy
Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification.
The Journal of clinical investigation 1991;87(2):597-601.
1991: Ricardo Uauy; Gloria Lena Vega; Scott M Grundy
Coinheritance of two mild defects in low density lipoprotein receptor function produces severe hypercholesterolemia.
The Journal of clinical endocrinology and metabolism 1991;72(1):179-87.
1991: Scott M Grundy; Gloria Lena Vega
What is meant by overproduction of apo B-containing lipoproteins?
Advances in experimental medicine and biology 1991;285():213-22.
1990: Scott M Grundy
Cholesterol and coronary heart disease. Future directions.
JAMA : the journal of the American Medical Association 1990;264(23):3053-9.
1990: Gloria Lena Vega; Scott M Grundy
Primary hypertriglyceridemia with borderline high cholesterol and elevated apolipoprotein B concentrations. Comparison of gemfibrozil vs lovastatin therapy.
JAMA : the journal of the American Medical Association 1990;264(21):2759-63.
1990: S Nozaki; Gloria Lena Vega; R J Haddox; E T Dolan; Scott M Grundy
Influence of lovastatin on concentrations and composition of lipoprotein subfractions.
Atherosclerosis 1990;84(2-3):101-10.
1990: Scott M Grundy; Gloria Lena Vega; Abhimanyu Garg
Use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in various forms of dyslipidemia.
The American journal of cardiology 1990;66(8):31B-38B.
1990: Scott M Grundy
HMG-CoA reductase inhibitors.
Journal of internal medicine 1990;228(3):201-5.
1990: Gloria Lena Vega; Scott M Grundy
Does measurement of apolipoprotein B have a place in cholesterol management?
Arteriosclerosis (Dallas, Tex.) 1990;10(5):668-71.
1990: Thomas L Innerarity; Robert W Mahley; Karl H Weisgraber; Thomas P Bersot; R M Krauss; Gloria Lena Vega; Scott M Grundy; W Friedl; Jean Davignon; B J McCarthy
Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia.
Journal of lipid research 1990;31(8):1337-49.
1990: Scott M Grundy; Gloria Lena Vega
Role of apolipoprotein levels in clinical practice.
Archives of internal medicine 1990;150(8):1579-82.
1990: Scott M Grundy; G Getz
Aspen Hepatic Cholesterol and Lipoprotein Conference 1989. Report of a conference.
Journal of lipid research 1990;31(7):1327-33.
1990: Scott M Grundy; Margo A Denke
Dietary influences on serum lipids and lipoproteins.
Journal of lipid research 1990;31(7):1149-72.
1990: Ishwarlal Jialal; Gloria Lena Vega; Scott M Grundy
Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein.
Atherosclerosis 1990;82(3):185-91.
1990: Gloria Lena Vega; Scott M Grundy
Management of primary mixed hyperlipidemia with lovastatin.
Archives of internal medicine 1990;150(6):1313-9.
1990: Margo A Denke; Scott M Grundy
Hypercholesterolemia in elderly persons: resolving the treatment dilemma.
Annals of internal medicine 1990;112(10):780-92.
1990: Abhimanyu Garg; Andrea Bonanome; Scott M Grundy; R H Unger; Neil A Breslau; Charles Y C Pak
Effects of dietary carbohydrates on metabolism of calcium and other minerals in normal subjects and patients with noninsulin-dependent diabetes mellitus.
The Journal of clinical endocrinology and metabolism 1990;70(4):1007-13.
1990: Abhimanyu Garg; Scott M Grundy
Therapeutic perspectives in hyperlipidemic patients with diabetes mellitus.
The Journal of diabetic complications 1990;4(2):72-4.
1990: T W Faust; Jan Redfern; I Podolsky; E Lee; Scott M Grundy; M Feldman
Effects of aspirin on gastric mucosal prostaglandin E2 and F2 alpha content and on gastric mucosal injury in humans receiving fish oil or olive oil.
Gastroenterology 1990;98(3):586-91.
1990: Scott M Grundy
Management of hyperlipidemia of kidney disease.
Kidney international 1990;37(3):847-53.
1990: Scott M Grundy; Gloria Lena Vega
Causes of high blood cholesterol.
Circulation 1990;81(2):412-27.
1990: Gloria Lena Vega; R M Krauss; Scott M Grundy
Pravastatin therapy in primary moderate hypercholesterolaemia: changes in metabolism of apolipoprotein B-containing lipoproteins.
Journal of internal medicine 1990;227(2):81-94.
1990: Scott M Grundy
Drug therapy in dyslipidemia.
Scandinavian journal of clinical and laboratory investigation. Supplementum 1990;199():63-72.
1990: Scott M Grundy
Cholesterol and coronary heart disease.
Scandinavian journal of clinical and laboratory investigation. Supplementum 1990;199():17-24.
1989: Gloria Lena Vega; Scott M Grundy
Comparison of lovastatin and gemfibrozil in normolipidemic patients with hypoalphalipoproteinemia.
JAMA : the journal of the American Medical Association 1989;262(22):3148-53.
1989: Andrea Bonanome; Scott M Grundy
Intestinal absorption of stearic acid after consumption of high fat meals in humans.
The Journal of nutrition 1989;119(11):1556-60.
1989: Scott M Grundy; Gloria Lena Vega
Rationale and management of hyperlipidemia of the nephrotic syndrome.
The American journal of medicine 1989;87(5N):3N-11N.
1989: Gloria Lena Vega; Scott M Grundy
Studies on mechanisms for enhanced clearance of low-density lipoproteins in patients with primary hypertriglyceridaemia.
Journal of internal medicine 1989;226(1):5-15.
1989: Gloria Lena Vega; Scott M Grundy
Estimation of turnover of low density lipoproteins by simplified methods.
Atherosclerosis 1989;76(2-3):139-48.
1989: Scott M Grundy
Monounsaturated fatty acids and cholesterol metabolism: implications for dietary recommendations.
The Journal of nutrition 1989;119(4):529-33.
1989: Gloria Lena Vega; C East; Scott M Grundy
Effects of combined therapy with lovastatin and colestipol in heterozygous familial hypercholesterolemia. Effects on kinetics of apolipoprotein B.
Arteriosclerosis (Dallas, Tex.) 1989;9(1 Suppl):I135-44.
1989: L F Soria; E H Ludwig; H R Clarke; Gloria Lena Vega; Scott M Grundy; B J McCarthy
Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(2):587-91.
1988: Karl H Weisgraber; Thomas L Innerarity; Yvonne Newhouse; Stephen G Young; Kay S Arnold; R M Krauss; Gloria Lena Vega; Scott M Grundy; Robert W Mahley
Familial defective apolipoprotein B-100: enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(24):9758-62.
1988: Abhimanyu Garg; Andrea Bonanome; Scott M Grundy; Z J Zhang; Roger H Unger
Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus.
The New England journal of medicine 1988;319(13):829-34.
1988: Ricardo Uauy; Gloria Lena Vega; Scott M Grundy; D M Bilheimer
Lovastatin therapy in receptor-negative homozygous familial hypercholesterolemia: lack of effect on low-density lipoprotein concentrations or turnover.
The Journal of pediatrics 1988;113(2):387-92.
1988: Scott M Grundy
HMG-CoA reductase inhibitors for treatment of hypercholesterolemia.
The New England journal of medicine 1988;319(1):24-33.
1988: Margo A Denke; Scott M Grundy
Hypertriglyceridemia: a relative contraindication to the use of bile acid-binding resins?
Hepatology (Baltimore, Md.) 1988;8(4):974-5.
1988: C East; D W Bilheimer; Scott M Grundy
Combination drug therapy for familial combined hyperlipidemia.
Annals of internal medicine 1988;109(1):25-32.
1988: Scott M Grundy
Cholesterol education program in the United States.
The Canadian journal of cardiology 1988;4 Suppl A():31A-35A.
1988: Scott M Grundy
Lessons from the Helsinki Heart Study. Fibric acid therapy for dyslipidemia.
Postgraduate medicine 1988;84(1):217-8, 223-31.
1988: Gloria Lena Vega; Scott M Grundy
Lovastatin therapy in nephrotic hyperlipidemia: effects on lipoprotein metabolism.
Kidney international 1988;33(6):1160-8.
1988: Andrea Bonanome; Scott M Grundy
Effect of dietary stearic acid on plasma cholesterol and lipoprotein levels.
The New England journal of medicine 1988;318(19):1244-8.
1988: Scott M Grundy; Gloria Lena Vega
Hypertriglyceridemia: causes and relation to coronary heart disease.
Seminars in thrombosis and hemostasis 1988;14(2):149-64.
1988: Gloria Lena Vega; C East; Scott M Grundy
Lovastatin therapy in familial dysbetalipoproteinemia: effects on kinetics of apolipoprotein B.
Atherosclerosis 1988;70(1-2):131-43.
1988: Gloria Lena Vega; Scott M Grundy
Pathogenesis of hypertriglyceridemia: implications for coronary heart disease and therapy.
Advances in experimental medicine and biology 1988;243():311-26.
1987: Thomas L Innerarity; Karl H Weisgraber; Kay S Arnold; Robert W Mahley; R M Krauss; Gloria Lena Vega; Scott M Grundy
Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(19):6919-23.
1987: Scott M Grundy; S C Kalser
Highlights of the meeting on prevention of gallstones.
Hepatology (Baltimore, Md.) 1987;7(5):946-51.
1986: C East; Scott M Grundy; D W Bilheimer
Normal cholesterol levels with lovastatin (mevinolin) therapy in a child with homozygous familial hypercholesterolemia following liver transplantation.
JAMA : the journal of the American Medical Association 1986;256(20):2843-8.
1986: C A East; Scott M Grundy; D W Bilheimer
Preliminary report: treatment of type 3 hyperlipoproteinemia with mevinolin.
Metabolism: clinical and experimental 1986;35(2):97-8.
1985: D W Bilheimer; C East; Scott M Grundy; J J Nora
Clinical studies in a kindred with a kinetic LDL receptor mutation causing familial hypercholesterolemia.
American journal of medical genetics 1985;22(3):593-8.